ArticleAmerican journal of public health2017
Tobacco Industry Research on Nicotine Replacement Therapy: "If Anyone Is Going to Take Away Our Business It Should Be Us".
Article in American journal of public health, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 1 synthesis or guideline pooled it, 30 citations in OpenAlex.
- Content Analysis of the Corporate Social Responsibility Practices of 9 Major Cannabis Companies in Canada and the US.JAMA network open · 2022Pooled it
- Trial
- Industrial Hemp and Tobacco as Multipurpose Crops: Traditional Uses, Contemporary Applications, and Future Perspectives.Plants (Basel, Switzerland) · 2026Review
- Exploring Glyoxalase Strategies for Managing Sugar-Induced Chronic Diseases.Life (Basel, Switzerland) · 2025Article
- An Observational Study of Nicotine Replacement Therapy Availability Through Pharmacist Prescribing in the California Central Valley.Tobacco use insights · 2025Article
- Pharmaceuticalisation as the tobacco industry's endgame.BMJ global health · 2024Article
- Online Tobacco Advertising and Current Chew, Dip, Snuff and Snus Use among Youth and Young Adults, 2018-2019.International journal of environmental research and public health · 2022Article
- Lucy-Novel Flavored Nicotine Gum, Lozenges, and Pouches: Are They Misleading Consumers?Substance use & misuse · 2022Article
- A public policy analysis with key stakeholders' insights to understand India's compliance with the WHO framework convention on tobacco control.Ecancermedicalscience · 2022Article
- Successful countering of tobacco industry efforts to overturn Thailand's ENDS ban.Tobacco control · 2021Article
- Observational
- Tobacco company strategies to identify and promote the benefits of nicotine.Tobacco control · 2019Article
- Health Care Provider Intervention and Utilization of Cessation Assistance in 12 Low- and Middle-Income Countries.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2019Article
- Heated tobacco products: another tobacco industry global strategy to slow progress in tobacco control.Tobacco control · 2018Article
- PMI's own in vivo clinical data on biomarkers of potential harm in Americans show that IQOS is not detectably different from conventional cigarettes.Tobacco control · 2018Article
- Comparison of volatile organic compounds between cigarette smoke condensate (CSC) and extract (CSE) samples.Environmental health and toxicology · 2018Article
- Public versus internal conceptions of addiction: An analysis of internal Philip Morris documents.PLoS medicine · 2018Article
- E-Cigarettes: Use, Effects on Smoking, Risks, and Policy Implications.Annual review of public health · 2018Article
- Perceptions of pharmacist-furnished nicotine replacement therapy among participants who smoke in California.Journal of the American Pharmacists Association : JAPhAArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
Abstract
Nicotine replacement therapy (NRT) is recommended for tobacco cessation on the basis of pharmaceutical industry research showing its effectiveness when combined with counseling. The tobacco industry opposed NRT when it first appeared in the 1980s but by 2016 was marketing its own NRT products. We used internal tobacco industry documents dated 1960 through 2010 to identify the industry's perceptions of NRT. As early as the 1950s, tobacco companies developed nonsmoked nicotine replacements for cigarettes, but they stopped out of concern that marketing such products would trigger Food and Drug Administration regulation of cigarettes. In the 1990s, after pharmaceutical companies began selling prescription NRT, tobacco companies found that many smokers used NRT to supplement smoking rather than to quit. In 2009, once the Food and Drug Administration began regulating tobacco, tobacco companies restarted their plans to capture the nicotine market. Although the tobacco industry initially viewed NRT as a threat, it found that smokers often combined NRT with smoking rather than using it as a replacement and began marketing their own NRT products.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.